AMICUS THERAPEUTICS, INC. — Director's Dealing 2025

Dec 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2025-12-26

Reporting Person: Campbell Bradley L (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-26	Common Stock	F	108602	$14.25	Disposed	1021180	Direct